Academic
Publications
A Specific Inhibitor of TGF-B Receptor Kinase, SB431542, as a Potent Antitumor Agent for Human Cancers1

A Specific Inhibitor of TGF-B Receptor Kinase, SB431542, as a Potent Antitumor Agent for Human Cancers1,Sunil K. Halder,R. Daniel Beauchamp,Pran K. Da

A Specific Inhibitor of TGF-B Receptor Kinase, SB431542, as a Potent Antitumor Agent for Human Cancers1   (Citations: 7)
BibTex | RIS | RefWorks Download
Small molecule inhibitors of signaling pathways have proven to be extremely useful for the development of therapeutic strategies for human cancers. Blocking the tumor-promoting effects of transforming growth factor-B (TGF-B) in advanced stage carcinogenesis pro- vides a potentially interesting drug target for thera- peutic intervention. Although very few TGF-B receptor kinase inhibitors (TRKI) are now emerging in preclinical studies, nothing is known about how these inhibitors might regulate the tumor-suppressive or tumor- promoting effects of TGF-B, or when these inhibitors might be useful for treatment during cancer progres- sion. We have investigated the potential of TRKI in new therapeutic approaches in preclinical models. Here, we demonstrate that the TRKI, SB-431542, inhibits TGF-B- induced transcription, gene expression, apoptosis, and growth suppression. We have observed that SB-431542 attenuates the tumor-promoting effects of TGF-B, including TGF-B-induced EMT, cell motility, migration and invasion, and vascular endothelial growth factor secretion in human cancer cell lines. Interestingly, SB-431542 induces anchorage independent growth of cells that are growth-inhibited by TGF-B, whereas it reduces colony formation by cells that are growth- promoted by TGF-B. However, SB-431542 has no effect on a cell line that failed to respond to TGF-B. This represents a novel potential application of these inhi- bitors as therapeutic agents for human cancers with the goal of blocking tumor invasion, angiogenesis, and metastasis, when tumors are refractory to TGF-B- induced tumor-suppressor functions but responsive to tumor-promoting effects of TGF-B. Neoplasia (2005) 7, 509 -521
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
Sort by: